Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line

Cancer Research

Volumn 65, Issue 13, 2005, Pages 5674-5682

  Demou, Zoe N ^a   Awad, Michael ^a   McKee, Trevor ^a,b   Perentes, Jean Yannis ^a,c   Wang, Xiaoye ^a   Munn, Lance L ^a   Jain, Rakesh K ^a   Boucher, Yves ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; COLLAGEN TYPE 1; FIBRILLAR COLLAGEN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TELOPEPTIDE;

AMOEBA; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL MIGRATION; CELL MOTION; CELL SHAPE; CELL SIZE; CELL STRAIN MDA MB 231; CELL STRUCTURE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MESENCHYME; METASTASIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; COLLAGEN; COLLAGEN TYPE I; HUMANS; NEOPLASM INVASIVENESS; PEPTIDES; RATS; RHOA GTP-BINDING PROTEIN;

EID: 21344459022     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1682     Document Type: Article

References (47)

1. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;17:375-9.
2. De Wever O, Marcel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-47.
3. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003;3:362-74.
4. Friedl P, Brocker EB. The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci 2000;57:41-64.
5. Albo D, Rothman VL, Roberts DD, Tuszynski GP. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor. Br J Cancer 2000;83:298-306.
6. Ntayi C, Lorimier S, Berthier-Vergnes O, Hornebeck W, Bernard P. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type 1 collagen lattices. Exp Cell Res 2001;270:110-8.
7. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001;276:24833-42.
8. Devreotes PN, Zigmond SH. Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu Rev Cell Biol 1988;4:649-86.
9. Wolf K, Mazo I, Leung H, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003;160:267-77.
10. Kuznetsova N, Leikin S. Does the triple helical domain of type I collagen encode molecular recognition and fiber assembly while telopeptides serve as catalytic domains? Effect of proteolytic cleavage on fibrillogenesis and on collagen-collagen interaction in fibers. J Biol Chem 1999;274:36083-8.
11. Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Annu Rev Biochem 1984;53:717-48.
12. Kemp P, Bell E, Falco L, et al: 0 419 111 B1, assignee. Collagen compositions and methods of preparation thereof. European Patent 1995.
13. Sato K, Ebihara T, Adachi E, Kawashima S, Hattori S, Irie S. Possible involvement of aminotelopeptide in self-assembly and thermal stability of collagen I as revealed by its removal with proteases. J Biol Chem 2000;275:25870-5.
14. Siegel RC, Pinnell SR, Martin GR. Cross-linking of collagen and elastin. Properties of lysyl oxidase. Biochemistry 1970;9:4486-92.
15. Siegel RC, Fu JC, Chang Y. Collagen cross-linking the substrate specificity of lysyl oxidase. Adv Exp Med Biol 1976;74:438-46.
16. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
17. Hasebe T, Mukai K, Tsuda H, Ochiai A. New prognostic histological parameter of invasive ductal carcinoma of the breast clinicopathological significance of fibrotic focus. Pathol Int 2000;50:263-72.
18. Kauppila S, Stenback F, Risteli J, Jukkola A, Risteli L. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 1998;186:262-8.
19. Kauppila S, Bode MK, Stenback F, Risteli L, Risteli J. Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo. Br J Cancer 1999;81:654-61.
20. Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA, Sommer P. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol 1997;150:497-507.
21. Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992;267:21712-9.
22. Knauper V, Cowell S, Smith B, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997;272:7608-16.
23. Shimada T, Nakamura H, Ohuchi E, et al. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur J Biochem 1999;262:907-14.
24. Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998;331:727-32.
25. Atley LM, Mort JS, Lalumiere M, Eyre DR. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope. Bone 2000;26:241-7.
26. Maemura M, Iino Y, Yokoe T, et al. Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer. Oncol Rep 2000;7:1333-8.
27. Simojoki M, Santala M, Risteli J, Kauppila A. Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer. Gynecol Oncol 2001;82:110-5.
28. Keskikuru R, Bloigu R, Risteli J, Kataja V, Jukkola A. Elevated preoperative serum ICTP is a prognostic factor for overall and disease-free survival in breast cancer. Oncol Rep 2002;9:1323-7.
29. Girton TS, Oegema TR, Tranquillo RT. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. J Biomed Mater Res 1999;46:87-92.
30. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003;5:711-9.
31. Burton K. An aperture-shifting light microscopic method for rapidly quantifying positions of cells in 3D matrices. Cytometry 2003;54:125-31.
32. Demou ZN, McIntire LV. Fully automated three-dimensional tracking of cancer cells in collagen gels: determination of motility phenotypes at the cellular level. Can Res 2002;62:5301-7.
33. Brown E, McKee T, diTomaso E, et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 2003;9:796-800.
34. Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G, Zanker KS. Migration of highly aggressive MV3 melanoma cells in 3D collagen lattices results in local matrix reorganization and shedding of α2 and β1 integrins and CD44. Can Res 1997;57:2061-70.
35. Wang N. Mechanical interactions among cytoskeletal filaments. Hypertension 1998;32:162-5.
36. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 2004;16:14-23.
37. Troup S, Njue C, Kliewer EV, et al. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Can Res 2003;9:207-14.
38. Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003;102:3262-9.
39. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-5.
40. Bouzahzah B, Albanese C, Ahmed F, et al. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 2001;7:816-30.
41. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002;2:133-42.
42. Croft DR, Sahai E, Mavria G, et al. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 2004;64:8994-9001.
43. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo AP. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 2000;269:652-9.
44. Nakajima M, Hayashi K, Katayama K, et al. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. Eur J Pharmacol 2003;459:113-20.
45. De Wever O, Nguyen QD, Van Hoorde L, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 2004;18:1016-8.
46. Zhou H, Kramer RH. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1. J Biol Chem 2005;280:10624-35.
47. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 2003;163:583-95.